PRIMR

PRIMR PRIMR creates simple illustrated videos to educate patients about cancer and clinical trials.

01/12/2026

🎯 A rising PSA can suggest prostate cancer has returned, even when CT or MRI look normal. In the AMPLIFY trial, advanced PSMA PET imaging uses a new tracer to better spot hidden cancer and help doctors target treatment more accurately.

Watch the IRB-approved video here:
https://www.primrmed.com/cancer-clinical-trials/amplify-trial



Produced in partnership with Clarity Pharmaceuticals.

simplifies study details with doctor-approved videos.AMPLIFY is enrolling prostate cancer patients with a rising PSA a...
01/12/2026

simplifies study details with doctor-approved videos.

AMPLIFY is enrolling prostate cancer patients with a rising PSA after prior treatment like surgery or radiation to evaluate advanced PSMA PET imaging for possible cancer recurrence.

Watch the IRB-approved video here:
https://www.primrmed.com/cancer-clinical-trials/amplify-trial



Produced in partnership with Clarity Pharmaceuticals.

Drive trial participation by enhancing patient understanding with PRIMR’s video solutions.Trusted content, better outcom...
01/08/2026

Drive trial participation by enhancing patient understanding with PRIMR’s video solutions.

Trusted content, better outcomes. 🎬👥

https://www.primrmed.com/

01/07/2026

▶️ Neutrophils are white blood cells that act as your body’s first defense against infection, but chemotherapy can lower them by affecting the bone marrow. Your care team monitors this with blood tests and may pause treatment or give meds to boost counts. Good hand and oral hygiene, safe food handling, avoiding sick contacts, and watching for fever can help reduce infection risk.

Learn more:
https://www.primrmed.com/cancer-education/neutropia

Neutrophils are the body's first lines of defense against infection.In this video, we'll talk more about what neutrophil...
01/07/2026

Neutrophils are the body's first lines of defense against infection.

In this video, we'll talk more about what neutrophils do and what you can do as a patient to prevent getting infections if you experience neutropenia from chemotherapy.

Learn more:
https://www.primrmed.com/cancer-education/neutropia

PRIMR provides sponsors with actionable data to stay ahead of patient and site engagement trends in clinical trials. 📈🔍h...
01/06/2026

PRIMR provides sponsors with actionable data to stay ahead of patient and site engagement trends in clinical trials. 📈🔍

https://www.primrmed.com/

01/05/2026

🎯 This clinical trial studying nuvisertib, which targets the PIM1 pathway that can drive MF and resistance to JAK inhibitors, could help. By adding or switching to nuvisertib, the study aims to improve symptoms and potentially restore response when JAK inhibitors stop working.

breaks down complex trial info visually.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/oral-tp-3654-for-patients-with-myelofibrosis



Sumitomo Pharma America - formerly Enzyvant

PRIMR delivers strategic foresight, enabling sponsors to optimize clinical trial recruitment and retention efforts. 🎯🔬ht...
12/23/2025

PRIMR delivers strategic foresight, enabling sponsors to optimize clinical trial recruitment and retention efforts. 🎯🔬

https://www.primrmed.com/

12/22/2025

🎯 Being ctDNA-positive after surgery means tiny cancer signals remain in the blood. The MODERN trial is testing whether adding a second immunotherapy, relatlimab, to standard nivolumab works better than nivolumab alone to reduce recurrence risk.

Watch the IRB-approved series:
[https://www.primrmed.com/cancer-clinical-trials/modern-trial](https://www.primrmed.com/cancer-clinical-trials/modern-trial)

doctor-reviewed videos build patient knowledge.



Matthew Galsky Stephanie Berg
Alliance for Clinical Trials in Oncology Natera

doctor-reviewed videos build patient knowledge.MODERN: Cohort A (ctDNA+ urothelial post-surgery) is studying whether d...
12/22/2025

doctor-reviewed videos build patient knowledge.

MODERN: Cohort A (ctDNA+ urothelial post-surgery) is studying whether dual immunotherapy improves outcomes vs standard nivolumab alone.

Watch the IRB-approved series:
https://www.primrmed.com/cancer-clinical-trials/modern-trial



Matthew Galsky Stephanie Berg
Alliance for Clinical Trials in Oncology | Natera

Empower trial participants with PRIMR’s trusted video content.Simplifying complex information for better decisions. 📹🧠ht...
12/18/2025

Empower trial participants with PRIMR’s trusted video content.

Simplifying complex information for better decisions. 📹🧠

https://www.primrmed.com/

Address

Hartford, CT
06117

Website

Alerts

Be the first to know and let us send you an email when PRIMR posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category